Insulet reported Non-GAAP EPS of $1.55, beating estimates by $0.09, and revenue of $783.8 million, surpassing estimates by $15.07 million.
18 Feb, 12:11 — 18 Feb, 12:27
Comparing sources…
AI-generated comparison of how 2 sources cover this story
Only the Reuters article covers Insulet's Q4 earnings, reporting that revenue beat estimates due to Omnipod's strength. The Seeking Alpha article focuses on Analog Devices, making it irrelevant to the Insulet story. Therefore, a direct comparison of coverage between different outlets on the same story is not possible.